content_image/232755.jpg
## A Business Model that Sustains Enterprise Value 

Astellas’ ultimate aim is to translate innovation into value for patients. W will concentrate our resources on ethical pharmaceuticals, particularly in the innovative drug business, and our efforts in resear ch and development (R&D) will be unwavering. Astellas champions a Global Category Leader (GCL) business model, based on which we establish a com - petitive edge by creating innovative pharmaceutical products in multiple therapeutic ar eas with a high level of unmet medical needs and deliver them to patients all over the world. We have alr eady established our position as a GCL in urology and transplantation, and we are now focusing our efforts on oncology as a thir d field. 

<img src='content_image/232755.jpg'>

